| |
|
|
| |
Pediatric Drug Delivery
Evolving Formulations, Emerging
Opportunities
|
Publication: Dec 2009
Product Code: PDD445R
|
Recent recognition and industry acceptance of the unique
therapeutic needs of pediatric patients has led to
regulatory activity and development programs that are
re-defining this market segment. The result has been a push
by developers and formulators emphasizing pediatric drug
delivery - the creation of formulations engineered and
packaged specifically for children to meet the needs of
pediatric patient populations. Several factors are driving
the growth of the pediatric drug delivery as a business
strategy. The pediatric sector is forecast to be one of the
fastest growing drug markets over the next ten years. By
circumventing the normal clinical trial and regulatory
approval process, off-label prescribing and extemporaneous
formulations add risk to pediatric prescribing. The growing
availability of drugs targeted for childhood illnesses is
focusing efforts on child-friendly delivery methods. To
encourage drug developers to perform clinical testing in
pediatric age groups for drugs anticipated to be used for
children, the FDA has published special rules and guidance
that include incentives. The European Commission adopted
similar regulations in 2005. These factors are converging to
drive developments in pediatric drug delivery. |
|
Highlights |
· Analyzes and evaluates
pediatric formulation and drug delivery activity and
assesses the market potential of existing and probable
future pediatric products
· Assesses key pediatric
drug therapy segments
· Provides detailed
evaluations of pediatric drug formulation and delivery
technology market factors and evolving business
opportunities
· Charts market segment
data and forecasts technology market share to 2012
· Profiles pediatric drug
formulation participants, their
technology development activities,
business strategies, and corporate
alliances and affiliations
|
|
Summary of Contents |
Executive Summary
Pediatric Drug Market
Dynamics
Factors Driving the Pediatric Market
Prevalence of Solid Oral Dosage Form (SODF)
Alternatives to SODF
Competitive Landscape
The Pediatric Market
Market Segments
Infant
Children/Pre-Adolescent
Adolescent
Demographic Factors
Age-related Disease Factors
Pediatric Drug Design Factors
Age-Appropriate Formulations
Ease of
Administration
Release Rate/Kinetics
Safety
Cost
Pediatric Formulation Technologies
Buccal & Transmucosal Films
Chewable Tablets
Product Strategies
Products and Pipeline
Prospects
Fast-Dissolve Formulations
Proprietary Technologies
Commercial Products
Syrups & Liquids
Oral Sprays
Sublingual
Formulations
Pediatric Formulation Factors
Dosing/Controlled Release
Matrix Technologies
Particle Engineering
Tablet/Capsule
Technology
Taste Masking
Emerging Technologies
Analysis of Important Pediatric Therapeutic
Segments
ADHD
Allergies
Analgesics
Antibiotics
Antivirals
Asthma
Childhood
Cancers
Cough/Cold Medications
Dermatology
Growth Deficiencies
Neurology
Vaccines
Market Factors
Extemporaneous Formulations
Regulations
Best Pharmaceuticals for Children Act
Pediatric Exclusivity
Pediatric Priority List
Pediatric Research Equity Act
European Regulation
on Medicines for Children
Pediatric Drug Studies
Pediatric Re-labeling
Drug Patent Life and IP
Factors
Business Risk and Opportunity Factors
Technology Differentiation
Pediatric Labeling
Product Branding
Formulation Approaches
Technology/Pharma Company Alliances
Pediatric
Drugs - Sector Company Profiles
|
|
|
|
|
